Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology

Papers
(The H4-Index of Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology is 31. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Living virus‐based nanohybrids for biomedical applications130
Next‐Generation Polymeric mRNA Nanocarriers: From Chemical Engineering to Organ‐Selective Gene Delivery102
The importance of the IL‐1 family of cytokines in nanoimmunosafety and nanotoxicology97
Strategies for Organ‐Targeted mRNA Delivery by Lipid Nanoparticles74
Toxicokinetics, dose–response, and risk assessment of nanomaterials: Methodology, challenges, and future perspectives71
Titanium dioxide nanoparticles: Recent progress in antimicrobial applications68
63
56
Market entry system considering the biosafety of nanomedical devices in China55
Spontaneous Self‐Organized Order Emerging From Intrinsically Disordered Protein Polymers53
Regulating photochemical properties of carbon dots for theranostic applications53
Cover Image, Volume 16, Issue 148
Cell surface‐nanoengineering for cancer targeting immunoregulation and precise immunotherapy48
Modulating osteoclasts with nanoparticles: A path for osteoporosis management?46
Recent advance in self‐assembled polymeric nanomedicines for gaseous signaling molecule delivery45
Fluorescent Nanodiamonds for Quantum Sensing in Biology43
Nanomaterials for hyperpolarized nuclear magnetic resonance and magnetic resonance imaging41
Nanomedicine against biofilm infections: A roadmap of challenges and limitations40
Advances in Microbial Diagnostics: Machine Learning and Nanotechnology for Zoonotic Disease Control39
Recent Advances in Cyclodextrin‐Based Nanoscale Drug Delivery Systems38
Nanotechnology‐driven strategies to enhance the treatment of drug‐resistant bacterial infections36
Issue Information36
The clinical progress and challenges of mRNA vaccines35
Advances in Engineered Virus‐Like Particles for Applications in Nanomedicine35
Innovative nanotheranostics: Smart nanoparticles based approach to overcome breast cancer stem cells mediated chemo‐ and radioresistances34
Recent developments in biosensing methods for extracellular vesicle protein characterization33
Nanoscale Radiotheranostics for Cancer Treatment: From Bench to Bedside33
Metal–organic coordination polymers for delivery of immunomodulatory agents, and infectious disease and cancer vaccines33
Harnessing the Power of D‐Alpha‐Tocopheryl Polyethylene Glycol Succinate‐Based Nanoparticles for Targeted Breast Cancer Therapy32
Development of Self‐Adjuvants in mRNA Vaccine and Its Application in Disease Prevention and Treatment31
Intranasal delivery of stem cells labeled by nanoparticles in neurodegenerative disorders: Challenges and opportunities31
0.85366606712341